Christoph von Klot

68Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging

Thorsten Derlin, Desiree Weiberg, Christoph von Klot et al. · European Radiology · 2016 · 88 citations

Medicine, Nuclear Medicine, Radiology +14

Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer

Sebastian C. Schmid, Alexander Geith, Alena Böker et al. · Advances in Therapy · 2014 · 77 citations

Medicine, Oncology, Urology +14

Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial

Maria De Santis, Joan Palou Redorta, Hiroyuki Nishiyama et al. · The Lancet · 2025 · 47 citations · Full text

Medicine, Oncology, Urology +13

Apoptosis gene polymorphisms and risk of prostate cancer: A hospital-based study of German patients treated with brachytherapy

Andreas Meyer, Irina Coinac, Natalia Bogdanova et al. · Urologic Oncology Seminars and Original Investigations · 2011 · 31 citations

Medicine, Oncology, Urology +12

Neoadjuvant targeted therapy in a primary metastasized renal cell cancer patient leads to down-staging of inferior vena cava thrombus (IVC) enabling a cardiopulmonary bypass-free tumor nephrectomy: a case report

Inga Peters, Michael Winkler, Björn Jüttner et al. · World Journal of Urology · 2012 · 26 citations

Medicine, Oncology, Surgery +16